Neurotech International Limited announced the appointment of Associate Professor Carolyn Ellaway as the Company's first Chief Medical Officer (CMO), commencing 1 August 2024. A/Prof Ellaway graduated from Melbourne University in 1991 and trained in Paediatrics and Clinical Genetics in Sydney and London. She is a Fellow of the Royal Australasia College of Paediatrics and a Clinical Associate Professor with Sydney University.
Carolyn currently consults at The Children's Hospital at Westmead, and Sydney Children's Hospital, Randwick. She also provides a private clinical genetics service for children at Lumina Kids' Brain & Mind Clinic in Lindfield. Her area of expertise is the diagnosis and management of children with a wide range of rare genetic disorders including mitochondrial and lysosomal storage disorders, Rett syndrome and related disorders.
Associate Professor Ellaway has published over 100 peer reviewed papers and book chapters.
